SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CYTC - How High Can It Go!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: g.w. barnard who wrote (132)11/29/1998 9:50:00 PM
From: Mike  Read Replies (2) of 185
 
Check out the news on CYTC this weekend. First CBS market watch has an article on CYTC that is headlined "Thin Prep is SIGNIFICANTLY better test". Second is Online Investor is featuring CYTC again. It is one of the featured stocks that went out to subscribers today-Sunday.

In looking over this stock it appears that the only ones who dont like the test are the ones worried about cost. I have seen no data to suggest that the test is any less effective than traditional Pap. Can anyone confirm this? In addition, I would not allow any other test to be performed on a family member with the current clinical evidence.

Can anyone address the cost issue associated with the Thin Prep vs regular Pap? I have seen that it is only $15-20 more expensive. What if CYTC was to cut the cost by say $5-$7. Would this increase acceptance and reduce margins but the volume would more than make up for reduced price? I have seen info that states margins are 75-80%. Can anyone let us know the cost structure and if this has already been discussed. Just let me know which post to read.

Thanks in advance,
Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext